Related Experiment Video
Updated: May 21, 2025

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
Circular RNA circHSPA8 Aggravates Metastasis by Acting as a Competitive Inhibitor of miR-195-5p to Upregulate WNT3A
Zhuoying Han1, Xiaojuan Yu2, Chenlong Wang1
1Department of Central Laboratory, The Affiliated Huaian No. 1 People's Hospital, Nanjing Medical University, Huai'an, China.
Abstract:
Circular RNA (circRNA) plays a vital role in the tumorigenicity and progression of cancer by regulating various biological behaviours. It acts as a microRNA sponge, disrupting transcription and the abnormal expression of oncogenes. Hsa_circ_0024715, a circRNA generated from cyclization at specific sites of the HSPA8 gene, has been found to be highly expressed in breast cancer (BC) tissue based on non-coding RNA high-throughput sequencing. However, its functions remain poorly understood. In this study, we performed qPCR to evaluate the expression of circHSPA8 in BC tissues. Survival analysis in a prospective cohort revealed that high expression of circHSPA8 is associated with poor prognosis and lymphoid node metastasis. Overexpression of circHSPA8 in MCF-7 cells significantly enhanced their proliferative and invasive abilities, whereas knockdown of circHSPA8 in MDA-MB-231 cells significantly reduced their proliferative and invasive abilities. We found that circHSPA8 can promote epithelial-mesenchymal transition (EMT) in BC cells, primarily by upregulating the expression of WNT3A. This process depends on the sponging and inhibition of miR-195-5p, which suppresses the proliferation, invasion, and metastasis of BC cells. In vivo experiments further confirmed that circHSPA8 can promote the intravasation and extravasation of BC cells as well as the formation of metastatic lesions in the lungs. In summary, these data demonstrate that circHSPA8 promotes EMT by acting as a competitive inhibitor of miR-195-5p to upregulate the expression of WNT3A in BC, suggesting that dysregulation of circRNA in BC might be a pathological factor and potential therapeutic target.
Insights
Circular RNA HSPA8 (circHSPA8) promotes breast cancer progression by enhancing cell proliferation and metastasis. It acts as a sponge for miR-195-5p, upregulating WNT3A and driving epithelial-mesenchymal transition (EMT).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) regulate gene expression and are implicated in cancer progression.
- Hsa_circ_0024715 (circHSPA8), derived from the HSPA8 gene, is upregulated in breast cancer (BC).
- The specific role of circHSPA8 in BC tumorigenesis is largely unknown.
Purpose of the Study:
- To investigate the function and mechanism of circHSPA8 in breast cancer.
- To determine the association between circHSPA8 expression and BC prognosis.
- To explore circHSPA8 as a potential therapeutic target.
Main Methods:
- Quantitative real-time PCR (qPCR) for circHSPA8 expression analysis.
- Survival analysis in a prospective cohort of BC patients.
- In vitro cell culture experiments (MCF-7, MDA-MB-231) with circHSPA8 overexpression and knockdown.
- In vivo metastasis models in mice.
Main Results:
- High circHSPA8 expression correlates with poor BC prognosis and lymph node metastasis.
- circHSPA8 overexpression enhances BC cell proliferation and invasion; knockdown reduces these abilities.
- circHSPA8 promotes epithelial-mesenchymal transition (EMT) by sponging miR-195-5p, leading to WNT3A upregulation.
- In vivo studies confirm circHSPA8 promotes BC cell intravasation, extravasation, and lung metastasis.
Conclusions:
- circHSPA8 acts as a crucial oncogenic circRNA in breast cancer.
- It promotes BC progression and metastasis via the miR-195-5p/WNT3A axis, driving EMT.
- circHSPA8 represents a potential diagnostic biomarker and therapeutic target for breast cancer.
Related Concept Videos
MicroRNAs
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Experimental RNAi
Abnormal Proliferation

